AYURF
Price
$0.02
Change
-$0.00 (-0.00%)
Updated
Aug 29 closing price
Capitalization
4.23M
BFRI
Price
$0.84
Change
-$0.00 (-0.00%)
Updated
Sep 5 closing price
Capitalization
9.01M
Interact to see
Advertisement

AYURF vs BFRI

Header iconAYURF vs BFRI Comparison
Open Charts AYURF vs BFRIBanner chart's image
AYURCANN
Price$0.02
Change-$0.00 (-0.00%)
Volume$10.11K
Capitalization4.23M
Biofrontera
Price$0.84
Change-$0.00 (-0.00%)
Volume$77.52K
Capitalization9.01M
AYURF vs BFRI Comparison Chart in %
Loading...
AYURF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BFRI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AYURF vs. BFRI commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AYURF is a Buy and BFRI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (AYURF: $0.02 vs. BFRI: $0.84)
Brand notoriety: AYURF and BFRI are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: AYURF: 40% vs. BFRI: 32%
Market capitalization -- AYURF: $4.23M vs. BFRI: $9.01M
AYURF [@Pharmaceuticals: Generic] is valued at $4.23M. BFRI’s [@Pharmaceuticals: Generic] market capitalization is $9.01M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.94B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AYURF’s FA Score shows that 0 FA rating(s) are green whileBFRI’s FA Score has 1 green FA rating(s).

  • AYURF’s FA Score: 0 green, 5 red.
  • BFRI’s FA Score: 1 green, 4 red.
According to our system of comparison, BFRI is a better buy in the long-term than AYURF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AYURF’s TA Score shows that 4 TA indicator(s) are bullish while BFRI’s TA Score has 3 bullish TA indicator(s).

  • AYURF’s TA Score: 4 bullish, 3 bearish.
  • BFRI’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, AYURF is a better buy in the short-term than BFRI.

Price Growth

AYURF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while BFRI (@Pharmaceuticals: Generic) price change was -4.72% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.10%. For the same industry, the average monthly price growth was +12.13%, and the average quarterly price growth was +87.01%.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.10% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BFRI($9.01M) has a higher market cap than AYURF($4.23M). AYURF YTD gains are higher at: 50.000 vs. BFRI (-22.541). AYURF has higher annual earnings (EBITDA): -1.61M vs. BFRI (-15.28M). BFRI has more cash in the bank: 7.25M vs. AYURF (1.08M). AYURF has less debt than BFRI: AYURF (2.74M) vs BFRI (5M). BFRI has higher revenues than AYURF: BFRI (39.2M) vs AYURF (29.8M).
AYURFBFRIAYURF / BFRI
Capitalization4.23M9.01M47%
EBITDA-1.61M-15.28M11%
Gain YTD50.000-22.541-222%
P/E RatioN/A0.89-
Revenue29.8M39.2M76%
Total Cash1.08M7.25M15%
Total Debt2.74M5M55%
TECHNICAL ANALYSIS
Technical Analysis
AYURFBFRI
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
89%
MACD
ODDS (%)
Bullish Trend 1 day ago
74%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
64%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
66%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 24 days ago
79%
Declines
ODDS (%)
N/A
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
85%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AYURF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BFRI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ORKA16.351.38
+9.22%
Oruka Therapeutics Inc
LUCY1.910.04
+2.14%
Innovative Eyewear Inc.
STHO8.720.14
+1.63%
Star Holdings
AMCR8.300.08
+0.94%
Amcor plc
EXTR21.70-0.75
-3.34%
Extreme Networks

AYURF and

Correlation & Price change

A.I.dvisor tells us that AYURF and PRFX have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AYURF and PRFX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AYURF
1D Price
Change %
AYURF100%
N/A
PRFX - AYURF
21%
Poorly correlated
-12.62%
HNSPF - AYURF
11%
Poorly correlated
N/A
STEK - AYURF
5%
Poorly correlated
-3.45%
BFRI - AYURF
3%
Poorly correlated
+0.64%
HLBBF - AYURF
-0%
Poorly correlated
N/A
More

BFRI and

Correlation & Price change

A.I.dvisor tells us that BFRI and ACET have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BFRI and ACET's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BFRI
1D Price
Change %
BFRI100%
+0.64%
ACET - BFRI
25%
Poorly correlated
+1.00%
DVAX - BFRI
23%
Poorly correlated
+0.80%
HCM - BFRI
23%
Poorly correlated
+7.61%
LNTH - BFRI
23%
Poorly correlated
+1.73%
EVO - BFRI
23%
Poorly correlated
+3.26%
More